Coreline Soft participated in the ‘6 International Advanced Medical Devices and Medical Industry Exhibition (KOAMEX 30)’ held at EXCO in Daegu for 7 days from Friday, June 2th to Sunday, July 3nd.
Coreline is taking a leading position in the medical AI market by developing ‘AVIEW LCS PLUS’, a simultaneous diagnosis solution for chest diseases, and supplying solutions to the domestic and overseas lung cancer screening business. It recently received approval from the Korea Exchange for preliminary screening for listing.
At this exhibition, we mainly introduced ‘AVIEW LCS’, an AI-based automatic lung nodule analysis solution. Deep learning technology accurately detects lung nodules in chest CT images and diagnoses them according to Lung-RADS, thereby assisting medical staff in making decisions.
‘AVIEW LCS’, which enables detailed explanations to patients by automatically generating readings and reports, supports follow-up tests, fully automatically analyzes lung nodules, and generates automatic result reports. It automatically matches nodules from previous tests to provide information on changed nodules, detects even the smallest nodules using deep learning technology, and automatically generates reporters containing quantitative results to help lung cancer screening test takers understand them.
Meanwhile, the main exhibition items of ‘KOAMEX 2023’ hosted by Daegu Metropolitan City and K-MEDI Hub are as follows. △Diagnostic and diagnostic devices such as scanners, measuring devices, and imaging devices △Clinical and inspection devices △Surgical and recycling devices △Hospital facilities and emergency equipment △Medical devices, parts, and services △Pharmaceutical devices △Medical services, SW
→ Go to KOAMEX 2023 News Special Page
